Background: The ultimate goal of locoregional therapy (LRT) to the liver is to induce total tumor necrosis. Trans-arterial chemoembolization (TACE) is the mainstay bridging therapy for patients with hepatocellular carcinoma (HCC) waiting for liver transplantation (LT). However, tumor response rate is variable. The purpose of this study was to correlate HCC radiological appearance with level of tumor necrosis during explant analysis from patients undergoing LT who received pre-LT TACE.
are more susceptible to TACE than lesions with arterial phase iso or hypoenhancement and lesions with infiltrative appearance. Pre-TACE CT imaging may ease the selection of an optimal treatment strategy for bridging patients with HCC to liver transplantation.
Background
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy as well as a worldwide leading cause of cancer mortality [1] . With most HCCs arising in a background of cirrhosis, liver transplantation (LT) stands as the most important potentially curative therapy [2] . However, a major drawback of LT is the significant scarcity of donors. In line with this, increases in waiting time have led to 20% of transplant candidates dropping out of the transplant waitlist [3] . Locoregional therapy (LRT) as a bridging strategy for patients on the waitlist aims to prevent tumor progression and downsize tumors to maintain transplant eligibility [4, 5] .
Among other LRT, trans-arterial chemoembolization (TACE) has been the most common implemented modality to treat patients with HCC not amenable to resection [6] . Considering that incomplete necrosis can be a risk factor for post-LT HCC recurrence [7] , the ultimate goal of TACE is to induce total tumor necrosis.
Assessment of tumor response to TACE via contrast enhanced (triphasic) crosssectional imaging is critical in determining the success of treatment and in guiding future therapy. Modified response evaluation criteria in solid tumors (mRESIST) consider the size of viable contrast-enhancing area within the tumor to evaluate response to LRT [8] . Unfortunately, accurate correlation of tumor size, number, percentage of necrosis and response to LRT between cross sectional imaging and histopathology is an ongoing challenge with 20%-40% radiologic underestimation of tumor burden [9] .
Although several studies have confirmed the correlation of the enhancement patterns and morphological image findings of HCC with tumor differentiation [10] [11] [12] , there is limited data regarding the correlation of the imaging characteristics of HCC lesions before and after TACE with pathological analysis. It has been suggested that complete retention of iodized oil in the tumor tends to correlate with complete tumor necrosis and improved survival [13] . Patients that demonstrated no relevant contrast enhancement on the post-TACE CT had significantly more extensive necrosis [14, 15] . Nevertheless, it is still unknown if the pre-TACE radiological appearances of HCC correlate with degree of tumor necrosis.
The purpose of this study was to correlate the pre-TACE radiological appearance of HCC assessed via CT with the level of tumor necrosis upon histopathological examination of the explanted liver after liver transplantation.
Methods

Study populations
A search was conducted in a prospectively maintained LT database between Jan, [17] . In all cases data from both the initial CT investigation and the last CT scan after TACE before LT if available were evaluated.
CT Technique and image evaluation
The pre-and post TACE multiphasic contrast enhanced studies of the enrolled subjects were performed on multidetector computed tomography (MDCT) scanners (ranging from 8 to 64 rows of detectors), with 0.6-to 1.5-mm collimation, 3-mm slice interval and 3-to 5-mm slice thickness. Patients were scanned before and after the intravenous administration of iodine contrast media in the arterial phase, portal-venous phase and equilibrium phase. The studies were retrospectively reviewed on commercially available workstations (MV1000, Siemens Healthcare, and IMPAX, Agfa Healthcare) simultaneously by two expert abdominal radiologists, and unaware of the explant histopathology findings.
The largest diameter of the enhancing portion of the lesions concerning for HCC on pre-TACE CT scan was measured on the imaging phase in which the lesion was best seen, and only lesions greater than or equal to 1-cm were included in the study.
The HCC attenuation in each phase was classified as hyper-attenuation, isoattenuation or hypo-attenuation compared with the surrounding liver parenchyma. A lesion with heterogeneous enhancement was regarded as hyper-attenuating when most of it was enhanced during the arterial phase compared with the pre-contrast phase. Hyper-attenuation on the arterial phase followed by washout in the portal or equilibrium phase was defined as "typical enhancement". A hypo-attenuated area with no change in the degree of attenuation during the dynamic phase was defined as necrosis. The shape of the tumor margin was categorized into three subgroups:
smooth; lobulated or infiltrative. Capsule appearance means a rim of hyperenhancement in portal, delayed, or transitional phase, which is unequivocally thicker than fibrotic tissue around background nodules [18] . 
Results
Characteristics of patients and tumors
Patient characteristics are summarized in 
Comparison of tumor necrosis according to mRECIST and histopathology
At explant histopathology analysis, the mean degree of tumor necrosis was 71.9 ± 32.3%. Tumor necrosis was rated as 0-30%, 31 [21] . While comparative studies revealed that TACE-based multi-modal treatments were safe and more beneficial than conservative management [22, 23] , improved post-LT survival in patients undergoing pre-LT TACE remains equivocal [24] . Nevertheless,
14
response to TACE has been established as a surrogate of tumor biology and instrumental to select patients to LT, as it has been observed that patients with favorable response to treatment have optimal post-LT outcome as opposed to those without favorable response [25, 26] .
Although the ultimate goal of LRT is to induce total tumor necrosis, the occurrence of this outcome is not achieved consistently and is subjected to a number of variables our population did show a shorter time from first TACE to OLT (with a mean of 197 and 108 days, respectively). Highly necrotic lesions are less prone to either local or systemic recurrence and therefore allow patients to remain on the waiting list for longer periods of time. Furthermore, the mean lesion per patient in our population was 2.09, compared to 1.3 in their study. Nevertheless, even though these variables were regarded as statistically significant in recent studies [8, 15] , none of them have been shown to influence the extension of necrosis in ours. While only 13 % (2 patients) of type B and C tumors showed near complete necrosis in the explant analysis, the proportion was 5 to 6 times larger (69%, 35 patients) for type A counterparts (p=0.000). These findings suggest that the use of parameters related to enhancement and margin may have a synergic predictor effect on the TACE outcome and therefore, it may be convenient to ponder both variables concomitantly before subjecting patients to such procedure.
Lower Child-Pugh score was the only non-imaging-related variable assessed in this study that showed statistical significance regarding TACE response (p=0.045). This association is consistently found in the studies [31, 32] and may be related to the more aggressive treatment regimen that patients with better functional liver status can tolerate, compared to that used in the context of more advanced liver disease. [14, 33, 34] .
This study is limited by the fact that we included patients treated over a wide period of time, using different CT equipment and TACE regimens. Furthermore, the estimation of tumor necrosis and the recognition of residual viable enhancing tumor can be particularly troublesome after Lipiodol-TACE due to the artifacts generated by the dense accumulation of the ethiodized oil [35] . Finally, this cohort only includes a restricted amount of patients who underwent both TACE and OLT. The small number of cases forced us to put together type B and type C tumors in one group before carrying out the analysis, preventing us from obtaining results for each type separately. It is also possible that the restriction in patients was partly responsible for the relatively low rate of a CR reported and the low incidence of repeated TACE, compared with the overall population of patients with HCC, especially those who have undergone selective TACE.
Conclusions
In conclusion, our study findings indicate that well circumscribed HCC lesions with arterial phase hyper enhancement are more susceptible to TACE compared to lesions with arterial phase iso-or hypo-enhancement and lesions with infiltrative appearance. By using this interpretation, CT could allow to narrow the selection criteria for TACE as well as to increase overall outcomes and prognosis of LT following bridging procedures. It is highly desirable to select patients with biologically favorable tumors for LT in order to avoid scarce organs being used for a questionable outcome. Nevertheless, more and larger studies are required to 18 validate the role and relevance of these imaging parameters. 
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25 Figure 1 Flow chart of the study population.
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Figure 2
Kaplan-Meier curve comparing overall survival (A) and recurrence-free survival (B) between
